Role of transforming growth factor-beta (TGF) beta in the physiopathology of rheumatoid arthritis;Papel del factor de crecimiento transformador-beta (TGF-β) en la fisiopatología de la artritis reumatoide

Reumatologia Clinica

Volumn 10, Issue 3, 2014, Pages 174-179

  Gonzalo Gil, Elena ^a   Galindo Izquierdo, María ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Animal models; Collagen induced arthritis; Rheumatoid artritis; T cells; Transforming growth factor beta

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA;

NONHUMAN; PATHOPHYSIOLOGY; RHEUMATOID ARTHRITIS; SHORT SURVEY;

EID: 84899927215     PISSN: 1699258X     EISSN: 18851398     Source Type: Journal    
DOI: 10.1016/j.reuma.2014.01.009     Document Type: Short Survey

References (85)

1. Pap T., Muller-Ladner U., Gay R.E., Gay S. Fibroblast biology. Role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis. Arthritis Res 2000, 2:361-367.
2. Sakuma M., Hatsushika K., Koyama K., Katoh R., Ando T., Watanabe Y., et al. TGF-beta type I receptor kinase inhibitor down-regulates rheumatoid synoviocytes and prevents the arthritis induced by type ii collagen antibody. Int Immunol 2007, 19:117-126.
3. Huber L.C., Distler O., Tarner I., Gay R.E., Gay S., Pap T. Synovial fibroblasts: Key players in rheumatoid arthritis. Rheumatology (Oxford) 2006, 45:669-675.
4. Bartok B., Firestein G.S. Fibroblast-like synoviocytes: Key effector cells in rheumatoid arthritis. Immunol Rev 2010, 233:233-255.
5. Kasperkovitz P.V., Timmer T.C., Smeets T.J., Verbeet N.L., Tak P.P., van Baarsen L.G., et al. Fibroblast-like synoviocytes derived from patients with rheumatoid arthritis show the imprint of synovial tissue heterogeneity: Evidence of a link between an increased myofibroblast-like phenotype and high-inflammation synovitis. Arthritis Rheum 2005, 52:430-441.
6. Lam J., Takeshita S., Barker J.E., Kanagawa O., Ross F.P., Teitelbaum S.L. TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J Clin Invest 2000, 106:1481-1488.
7. Lubberts E., van den Bersselaar L., Oppers-Walgreen B., Schwarzenberger P., Coenen-de Roo C.J., Kolls J.K., et al. IL-17 promotes bone erosion in murine collagen-induced arthritis through loss of the receptor activator of NF-kappa B ligand/osteoprotegerin balance. J Immunol 2003, 170:2655-2662.
8. Li H., Hong S., Qian J., Zheng Y., Yang J., Yi Q. Cross talk between the bone and immune systems: Osteoclasts function as antigen-presenting cells and activate CD4+ and CD8+ T cells. Blood 2010, 116:210-217.
9. Sarkissian M., Lafyatis R. Transforming growth factor-beta and platelet derived growth factor regulation of fibrillar fibronectin matrix formation by synovial fibroblasts. J Rheumatol 1998, 25:613-622.
10. Qu Z., Huang X.N., Ahmadi P., Andresevic J., Planck S.R., Hart C.E., et al. Expression of basic fibroblast growth factor in synovial tissue from patients with rheumatoid arthritis and degenerative joint disease. Lab Invest 1995, 73:339-346.
11. Massague J. The transforming growth factor-beta family. Annu Rev Cell Biol 1990, 6:597-641.
12. Shull M.M., Ormsby I., Kier A.B., Pawlowski S., Diebold R.J., Yin M., et al. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 1992, 359:693-699.
13. Chen R.H., Ebner R., Derynck R. Inactivation of the type ii receptor reveals two receptor pathways for the diverse TGF-beta activities. Science 1993, 260:1335-1338.
14. Varga J., Pasche B. Transforming growth factor beta as a therapeutic target in systemic sclerosis. Nat Rev Rheumatol 2009, 5:200-206.
15. Arias M., Sauer-Lehnen S., Treptau J., Janoschek N., Theuerkauf I., Buettner R., et al. Adenoviral expression of a transforming growth factor-beta1 antisense mRNA is effective in preventing liver fibrosis in bile-duct ligated rats. BMC Gastroenterol 2003, 3:29.
16. Philipp K., Riedel F., Germann G., Hormann K., Sauerbier M. TGF-beta antisense oligonucleotides reduce mRNA expression of matrix metalloproteinases in cultured wound-healing-related cells. Int J Mol Med 2005, 15:299-303.
17. Denis M. Neutralization of transforming growth factor-beta 1 in a mouse model of immune-induced lung fibrosis. Immunology 1994, 82:584-590.
18. McCormick L.L., Zhang Y., Tootell E., Gilliam A.C. Anti-TGF-beta treatment prevents skin and lung fibrosis in murine sclerodermatous graft-versus-host disease: A model for human scleroderma. J Immunol 1999, 163:5693-5699.
19. Ezquerro I.J., Lasarte J.J., Dotor J., Castilla-Cortazar I., Bustos M., Penuelas I., et al. A synthetic peptide from transforming growth factor beta type iii receptor inhibits liver fibrogenesis in rats with carbon tetrachloride liver injury. Cytokine 2003, 22:12-20.
20. Santiago B., Gutierrez-Canas I., Dotor J., Palao G., Lasarte J.J., Ruiz J., et al. Topical application of a peptide inhibitor of transforming growth factor-beta1 ameliorates bleomycin-induced skin fibrosis. J Invest Dermatol 2005, 125:450-455.
21. Kondou H., Mushiake S., Etani Y., Miyoshi Y., Michigami T., Ozono K. A blocking peptide for transforming growth factor-beta1 activation prevents hepatic fibrosis in vivo. J Hepatol 2003, 39:742-748.
22. Moustakas A., Pardali K., Gaal A., Heldin C.H. Mechanisms of TGF-beta signaling in regulation of cell growth and differentiation. Immunol Lett 2002, 82:85-91.
23. Dickson M.C., Martin J.S., Cousins F.M., Kulkarni A.B., Karlsson S., Akhurst R.J. Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice. Development 1995, 121:1845-1854.
24. Kulkarni A.B., Karlsson S. Transforming growth factor-beta 1 knockout mice. A mutation in one cytokine gene causes a dramatic inflammatory disease. Am J Pathol 1993, 143:3-9.
25. Schramm C., Kriegsmann J., Protschka M., Huber S., Hansen T., Schmitt E., et al. Susceptibility to collagen-induced arthritis is modulated by TGFbeta responsiveness of T cells. Arthritis Res Ther 2004, 6:R114-R119.
26. Kuruvilla A.P., Shah R., Hochwald G.M., Liggitt H.D., Palladino M.A., Thorbecke G.J. Protective effect of transforming growth factor beta 1 on experimental autoimmune diseases in mice. Proc Natl Acad Sci U S A 1991, 88:2918-2921.
27. Santambrogio L., Hochwald G.M., Leu C.H., Thorbecke G.J. Antagonistic effects of endogenous and exogenous TGF-beta and TNF on auto-immune diseases in mice. Immunopharmacol Immunotoxicol 1993, 15:461-478.
28. Brandes M.E., Allen J.B., Ogawa Y., Wahl S.M. Transforming growth factor beta 1 suppresses acute and chronic arthritis in experimental animals. J Clin Invest 1991, 87:1108-1113.
29. Song X.Y., Gu M., Jin W.W., Klinman D.M., Wahl S.M. Plasmid DNA encoding transforming growth factor-beta1 suppresses chronic disease in a streptococcal cell wall-induced arthritis model. J Clin Invest 1998, 101:2615-2621.
30. Park M.J., Park H.S., Cho M.L., Oh H.J., Cho Y.G., Min S.Y., et al. Transforming growth factor beta-transduced mesenchymal stem cells ameliorate experimental autoimmune arthritis through reciprocal regulation of Treg/Th17 cells and osteoclastogenesis. Arthritis Rheum 2011, 63:1668-1680.
31. Marinova-Mutafchieva L., Gabay C., Funa K., Williams R.O. Remission of collagen-induced arthritis is associated with high levels of transforming growth factor-beta expression in the joint. Clin Exp Immunol 2006, 146:287-293.
32. Sancho D., Gomez M., Viedma F., Esplugues E., Gordon-Alonso M., Garcia-Lopez M.A., et al. CD69 downregulates autoimmune reactivity through active transforming growth factor-beta production in collagen-induced arthritis. J Clin Invest 2003, 112:872-882.
33. Thorbecke G.J., Shah R., Leu C.H., Kuruvilla A.P., Hardison A.M., Palladino M.A. Involvement of endogenous tumor necrosis factor alpha and transforming growth factor beta during induction of collagen type ii arthritis in mice. Proc Natl Acad Sci U S A 1992, 89:7375-7379.
34. Van Beuningen H.M., van der Kraan P.M., Arntz O.J., van den Berg W.B. Transforming growth factor-beta 1 stimulates articular chondrocyte proteoglycan synthesis and induces osteophyte formation in the murine knee joint. Lab Invest 1994, 71:279-290.
35. Fava R.A., Olsen N.J., Postlethwaite A.E., Broadley K.N., Davidson J.M., Nanney L.B., et al. Transforming growth factor beta 1 (TGF-beta 1) induced neutrophil recruitment to synovial tissues: Implications for TGF-beta-driven synovial inflammation and hyperplasia. J Exp Med 1991, 173:1121-1132.
36. Allen J.B., Manthey C.L., Hand A.R., Ohura K., Ellingsworth L., Wahl S.M. Rapid onset synovial inflammation and hyperplasia induced by transforming growth factor beta. J Exp Med 1990, 171:231-247.
37. Wahl S.M., Allen J.B., Costa G.L., Wong H.L., Dasch J.R. Reversal of acute and chronic synovial inflammation by anti-transforming growth factor beta. J Exp Med 1993, 177:225-230.
38. Dotor J., Lopez-Vazquez A.B., Lasarte J.J., Sarobe P., Garcia-Granero M., Riezu-Boj J.I., et al. Identification of peptide inhibitors of transforming growth factor beta 1 using a phage-displayed peptide library. Cytokine 2007, 39:106-115.
39. Gonzalo-Gil E., Criado G., Santiago B., Dotor J., Pablos J.L., Galindo M. TGF-beta signalling is increased in rheumatoid synovium but TGF-beta blockade does not modify experimental arthritis. Clin Exp Immunol 2013, 174:245-255.
40. Carrier Y., Yuan J., Kuchroo V.K., Weiner H.L. Th3 cells in peripheral tolerance. I. I Induction of Foxp3-positive regulatory T cells by Th3 cells derived from TGF-beta T cell-transgenic mice. J Immunol 2007, 178:179-185.
41. Carrier Y., Yuan J., Kuchroo V.K., Weiner H.L. Th3 cells in peripheral tolerance. II. TGF-beta-transgenic Th3 cells rescue IL-2-deficient mice from autoimmunity. J Immunol 2007, 178:172-178.
42. Morgan M.E., Sutmuller R.P., Witteveen H.J., van Duivenvoorde L.M., Zanelli E., Melief C.J., et al. CD25+ cell depletion hastens the onset of severe disease in collagen-induced arthritis. Arthritis Rheum 2003, 48:1452-1460.
43. Ohata J., Miura T., Johnson T.A., Hori S., Ziegler S.F., Kohsaka H. Enhanced efficacy of regulatory T cell transfer against increasing resistance, by elevated Foxp3 expression induced in arthritic murine hosts. Arthritis Rheum 2007, 56:2947-2956.
44. Yang X.O., Pappu B.P., Nurieva R., Akimzhanov A., Kang H.S., Chung Y., et al. T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma. Immunity 2008, 28:29-39.
45. Ivanov I.I., McKenzie B.S., Zhou L., Tadokoro C.E., Lepelley A., Lafaille J.J., et al. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 2006, 126:1121-1133.
46. Korn T., Bettelli E., Gao W., Awasthi A., Jager A., Strom T.B., et al. IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature 2007, 448:484-487.
47. Nurieva R., Yang X.O., Martinez G., Zhang Y., Panopoulos A.D., Ma L., et al. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 2007, 448:480-483.
48. Veldhoen M., Hocking R.J., Flavell R.A., Stockinger B. Signals mediated by transforming growth factor-beta initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease. Nat Immunol 2006, 7:1151-1156.
49. Ghoreschi K., Laurence A., Yang X.P., Tato C.M., McGeachy M.J., Konkel J.E., et al. Generation of pathogenic T(H)17 cells in the absence of TGF-beta signalling. Nature 2010, 467:967-971.
50. Das J., Ren G., Zhang L., Roberts A.I., Zhao X., Bothwell A.L., et al. Transforming growth factor beta is dispensable for the molecular orchestration of Th17 cell differentiation. J Exp Med 2009, 206:2407-2416.
51. Lee Y., Awasthi A., Yosef N., Quintana F.J., Xiao S., Peters A., et al. Induction and molecular signature of pathogenic T(H)17 cells. Nat Immunol 2012, 13:991-999.
52. Raposo B.R., Rodrigues-Santos P., Carvalheiro H., Agua-Doce A.M., Carvalho L., Pereira da Silva J.A., et al. Monoclonal anti-CD8 therapy induces disease amelioration in the K/BxN mouse model of spontaneous chronic polyarthritis. Arthritis Rheum 2010, 62:2953-2962.
53. Huber M., Heink S., Grothe H., Guralnik A., Reinhard K., Elflein K., et al. A Th17-like developmental process leads to CD8(+) Tc17 cells with reduced cytotoxic activity. Eur J Immunol 2009, 39:1716-1725.
54. Mantel P.Y., Schmidt-Weber C.B. Transforming growth factor-beta: Recent advances on its role in immune tolerance. Methods Mol Biol 2011, 677:303-338.
55. Tada Y., Ho A., Koh D.R., Mak T.W. Collagen-induced arthritis in CD4- or CD8-deficient mice: CD8+ T cells play a role in initiation and regulate recovery phase of collagen-induced arthritis. J Immunol 1996, 156:4520-4526.
56. Ehinger M., Vestberg M., Johansson A.C., Johannesson M., Svensson A., Holmdahl R. Influence of CD4 or CD8 deficiency on collagen-induced arthritis. Immunology 2001, 103:291-300.
57. Waldrip W.R., Bikoff E.K., Hoodless P.A., Wrana J.L., Robertson E.J. Smad2 signaling in extraembryonic tissues determines anterior-posterior polarity of the early mouse embryo. Cell 1998, 92:797-808.
58. Blaney Davidson E.N., Vitters E.L., van der Kraan P.M., van den Berg W.B. Expression of transforming growth factor-beta (TGFbeta) and the TGFbeta signalling molecule SMAD-2P in spontaneous and instability-induced osteoarthritis: Role in cartilage degradation, chondrogenesis and osteophyte formation. Ann Rheum Dis 2006, 65:1414-1421.
59. Bira Y., Tani K., Nishioka Y., Miyata J., Sato K., Hayashi A., et al. Transforming growth factor beta stimulates rheumatoid synovial fibroblasts via the type ii receptor. Mod Rheumatol 2005, 15:108-113.
60. Kehrl J.H., Wakefield L.M., Roberts A.B., Jakowlew S., Alvarez-Mon M., Derynck R., et al. Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med 1986, 163:1037-1050.
61. Cheon H., Yu S.J., Yoo D.H., Chae I.J., Song G.G., Sohn J. Increased expression of pro-inflammatory cytokines and metalloproteinase-1 by TGF-beta1 in synovial fibroblasts from rheumatoid arthritis and normal individuals. Clin Exp Immunol 2002, 127:547-552.
62. Buckley C.D., Amft N., Bradfield P.F., Pilling D., Ross E., Arenzana-Seisdedos F., et al. Persistent induction of the chemokine receptor CXCR4 by TGF-beta 1 on synovial T cells contributes to their accumulation within the rheumatoid synovium. J Immunol 2000, 165:3423-3429.
63. Berse B., Hunt J.A., Diegel R.J., Morganelli P., Yeo K., Brown F., et al. Hypoxia augments cytokine (transforming growth factor-beta (TGF-beta) and IL-1)-induced vascular endothelial growth factor secretion by human synovial fibroblasts. Clin Exp Immunol 1999, 115:176-182.
64. Kim G., Jun J.B., Elkon K.B. Necessary role of phosphatidylinositol 3-kinase in transforming growth factor beta-mediated activation of Akt in normal and rheumatoid arthritis synovial fibroblasts. Arthritis Rheum 2002, 46:1504-1511.
65. Brennan F.M., Chantry D., Turner M., Foxwell B., Maini R., Feldmann M. Detection of transforming growth factor-beta in rheumatoid arthritis synovial tissue: Lack of effect on spontaneous cytokine production in joint cell cultures. Clin Exp Immunol 1990, 81:278-285.
66. Pohlers D., Beyer A., Koczan D., Wilhelm T., Thiesen H.J., Kinne R.W. Constitutive upregulation of the transforming growth factor-beta pathway in rheumatoid arthritis synovial fibroblasts. Arthritis Res Ther 2007, 9:R59.
67. Firestein G.S. Evolving concepts of rheumatoid arthritis. Nature 2003, 423:356-361.
68. Kremer J.M., Westhovens R., Leon M., Di Giorgio E., Alten R., Steinfeld S., et al. Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig. N Engl J Med 2003, 349:1907-1915.
69. Ouyang W., Beckett O., Ma Q., Li M.O. Transforming growth factor-beta signaling curbs thymic negative selection promoting regulatory T cell development. Immunity 2010, 32:642-653.
70. Kulkarni A.B., Huh C.G., Becker D., Geiser A., Lyght M., Flanders K.C., et al. Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci U S A 1993, 90:770-774.
71. Christ M., McCartney-Francis N.L., Kulkarni A.B., Ward J.M., Mizel D.E., Mackall C.L., et al. Immune dysregulation in TGF-beta 1-deficient mice. J Immunol 1994, 153:1936-1946.
72. Liu Y., Zhang P., Li J., Kulkarni A.B., Perruche S., Chen W. A critical function for TGF-beta signaling in the development of natural CD4+CD25+Foxp3+ regulatory T cells. Nat Immunol 2008, 9:632-640.
73. Chen W., Jin W., Hardegen N., Lei K.J., Li L., Marinos N., et al. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 2003, 198:1875-1886.
74. Tone Y., Furuuchi K., Kojima Y., Tykocinski M.L., Greene M.I., Tone M. Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer. Nat Immunol 2008, 9:194-202.
75. Nakamura K., Kitani A., Strober W. Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J Exp Med 2001, 194:629-644.
76. Marie J.C., Letterio J.J., Gavin M., Rudensky A.Y. TGF-beta1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells. J Exp Med 2005, 201:1061-1067.
77. Hinz S., Pagerols-Raluy L., Oberg H.H., Ammerpohl O., Grussel S., Sipos B., et al. Foxp3 expression in pancreatic carcinoma cells as a novel mechanism of immune evasion in cancer. Cancer Res 2007, 67:8344-8350.
78. Gorelik L., Constant S., Flavell R.A. Mechanism of transforming growth factor beta-induced inhibition of T helper type 1 differentiation. J Exp Med 2002, 195:1499-1505.
79. Gorelik L., Fields P.E., Flavell R.A. Cutting edge: TGF-beta inhibits Th type 2 development through inhibition of GATA-3 expression. J Immunol 2000, 165:4773-4777.
80. Acosta-Rodriguez E.V., Napolitani G., Lanzavecchia A., Sallusto F. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol 2007, 8:942-949.
81. Yang L., Anderson D.E., Baecher-Allan C., Hastings W.D., Bettelli E., Oukka M., et al. IL-21 and TGF-beta are required for differentiation of human T(H)17 cells. Nature 2008, 454:350-352.
82. Eljaafari A., Tartelin M.L., Aissaoui H., Chevrel G., Osta B., Lavocat F., et al. Bone marrow-derived and synovium-derived mesenchymal cells promote Th17 cell expansion and activation through caspase 1 activation: Contribution to the chronicity of rheumatoid arthritis. Arthritis Rheum 2012, 64:2147-2157.
83. Dardalhon V., Awasthi A., Kwon H., Galileos G., Gao W., Sobel R.A., et al. IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells. Nat Immunol 2008, 9:1347-1355.
84. Jager A., Dardalhon V., Sobel R.A., Bettelli E., Kuchroo V.K. Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes. J Immunol 2009, 183:7169-7177.
85. Beriou G., Bradshaw E.M., Lozano E., Costantino C.M., Hastings W.D., Orban T., et al. TGF-beta induces IL-9 production from human Th17 cells. J Immunol 2010, 185:46-54.